Clinical trial
Eplerenone, ACE Inhibition and Albuminuria
NCT00315016 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Eplerenone, ACE Inhibition and Albuminuria
- Lead sponsor
- Radboud University Medical Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 2007
- Completion date
- July 31, 2011
- Enrollment
- 30 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic nephropathy